Tanabe Pharma Korea
- Address: 24, Yeoui-daero, Yeongdeungpo-gu, Seoul, Republic of Korea
- Website: kr.tanabe-pharma.com
Tanabe Pharma Korea is a subsidiary of Tanabe Pharma Corporation, a leading Japanese pharmaceutical company, integrating both production and sales functions.
In production, we manufacture high-quality injectables at global GMP-compliant facilities, exporting to Germany, Japan, and China. We are committed to expanding our global partnerships and promoting the excellence of Korean pharmaceuticals.
In sales, our portfolio includes the highly regarded Eglandin for transplants and the cardiovascular agent Herben. We also successfully launched Radicut for ALS 2015, Dysval for Tardive Dyskinesia 2021, and Vadanem for renal anemia 2023.
We remain dedicated to contributing to global health through innovative products and striving to be a socially trusted international company.
In production, we manufacture high-quality injectables at global GMP-compliant facilities, exporting to Germany, Japan, and China. We are committed to expanding our global partnerships and promoting the excellence of Korean pharmaceuticals.
In sales, our portfolio includes the highly regarded Eglandin for transplants and the cardiovascular agent Herben. We also successfully launched Radicut for ALS 2015, Dysval for Tardive Dyskinesia 2021, and Vadanem for renal anemia 2023.
We remain dedicated to contributing to global health through innovative products and striving to be a socially trusted international company.